burn2ttxl的部落格

A patentable creative thinking is an creative thinking that is "novel" lower than 35 U.S.C.A. § 102, "useful" low 35 U.S.C.A. § 101, and "nonobvious" underneath 35 U.S.C.A. § 103. Section 103(a) of the Patent Act sets away the constant quantity of the noticeableness requirement:

A official document may not be obtained on the other hand the creative thinking is not identically disclosed or delineate as set away in Section 102 of this title, if the differences involving the matter substance sought to be patented and the prior art must not be such that the idea issue as a undivided would have been demonstrable at the incident the invention was made to a soul having standard swiftness in the art to which aforesaid matter concern pertains.

In Graham v. John Deere Co., 383 U.S. 1, 17 (1966), the United States Supreme Court interpreted this lexis to be a sign of that the best resolution on the part of noticeability is doped as a ask of law but is supported on actual inquires that regard (1) the breadth and joyful of the prior art; (2) the differences betwixt the preceding art and the claimed invention; (3) the plane of ability in the art; and (4) the target trace of non-obviousness.

To get hold of a exclusive rights on a new chemical compound, the combined must come across the nonobviousness criterion at the circumstance it is invented. Special issues, however, uprise beside natural science patents because far removed from physical phenomenon and mechanistic sciences, natural science is an episodic art. Minor changes in structures can dramatically feeling a compound's properties. Thus, it is inherently laborious for a tribunal to establish the noticeableness of a claimed cleft near a related artefact to that of a preceding art.

The degree of the confront to establish the conspicuousness of natural science compounds can be illustrated by the issues featured by the judicature in Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, 231 F.3d 1339 (Fed. Cir. 2000). In Yamanouchi, the disagreement central on whether one accomplished in the art would have well thought out it barefaced to form the drug Famotidine by (1) combine the charged process from head combined 44 with the customized heterocycle from Tiotidine to method an second compound, and (2) work the carbamoyl bundle in the second tripinnate with a sulfamoyl section to devise Famotidine as shown down in Scheme 1. It was very well glorious that some Tiotidine and Tagamet were preceding compounds, of which Tagamet was a thriving drug in market stand patch Tiotidine failed in preclinical trials due to its flooding definite quantity. Both compounds, however, showed elevated effectivity as inhibitors of viscus vitriolic organic process.

The panel in Yamanouchi upheld the unobstructed hostile an averment of noticeability. Id. at 1345. The tribunal explained, "For a chemic compound, a leading facie valise of patency requires a display of 'structural likeness relating claimed and prior art subject matter issue ... where on earth the anterior art gives pretext or need to brand the claimed compositions.'" Id. at 1343 (quoting In re Dillon, 919 F.3d 688, 692 (Fed. Cir. 1990)). Even yet the claimed combination messed up the mental testing of structural similarity, the Yamanouchi board invalidated a major facie bag of noticeability based on a paucity of need to reaper the antecedent art to create the claimed excogitation with similar life drive to that of the anterior art.

A. Structural similarity

Structural sameness between chemic compounds has efficaciously created a alone and distracting state of exclusive rights law. In re Jones, 958 F.2d 347, 350 (Fed. Cir. 1992). In influential the patency of a orthodox natural science compound, courts antecedently firm on the uniformity concerning the structures of a claimed merged and that of a compound disclosed in the prior art. In re Hass, 141 F.2d 122 (C.C.P.A 1944); In re Henze, 181 F.2d 196 (C.C.P.A. 1950).

In Hass, the claimed incised was a homolog of a prior art parted (Scheme 2). See Hass, 141 F.2d at 125. There was individual one more than carbon part in the claimed rough than that in the antecedent art. The Court of Claims and Patent Appeals held that the claimed abruptly-pinnate was not patentable unless it unconcealed "some nonobvious or unhoped-for beneficial properties not obsessed by the homologous bipartite unveiled in the preceding art." Id. The at large generality at the rear the court's conclusion was that chemic and ecological properties vary just a tad concerning members of a homologous string. Id. The Henze travel case transformed this generality into a supposal that was rebuttable if the contestant showed "that the claimed bipinnate possesses unobvious or surprise beneficial properties not in reality obsessed by the preceding art homologues." In re Henze, 181 F.2d at 201. Clearly some courts perceived natural science house and natural science properties as two contradictory considerations. Therefore, for structurally analogous chemic homologues, a new abruptly-pinnate was deemed leading facie in full view because a man of science could look forward to or pretend that the new chemical trilobated would have the selfsame properties in a specified group as did a the same antecedent art compound.

B. Inseparable skeleton and its properties

After division 103 was enacted, courts at a snail's pace moved to a more than holistic estimation of natural science compounds that reasoned chemical properties in addendum to natural science structures. In re Papesch, 315 F.2d 381 (C.C.P.A. 1971). In ­Papesch, an plaintiff claimed a line of compounds together with typical palmate 2,4,6-triethylpyrazolo(4,3-d)-4,5,6,7-tetrahydropyrimidine-5,7-dione (ethyl = CH2CH3), which was avowedly "structurally obvious" in oil lamp of a claimed trilobated 2,4,6-trimethylpyrazolo(4,3-d)-4,5,6.7-tetrahydropyrimidine-5,7-dione (methyl = CH3) as shown in Scheme 3. Id. at 384.

Comparative tests of the trimethyl bipinnate and the applicant's triethyl combined showed that the latter was an helpful medicament causal agency piece the prior art lobate was smarmy unused for that utility-grade. The Papesch board expressed that the properties of compounds were in hand to obviousness, emphasizing that the conception as a integral was a imparipinnate beside its own properties. Id. at 390. Additionally, the trial found that support of non-obvious or unexpectedly expedient properties not shared by the antecedent art ternate may refute a starring facie covering of noticeability. Id. at 391.

A complex and all of its properties are inseparable; they are one and the same entry .... But a guidelines is not a bilobate and piece it may tennis stroke in a contention to identity what is existence patented, as the metes and bound of a action identify a strategy of land, the piece that is patented is not the method but the bilobate known by it. And the patentability of the entity does not depend on the equality of its method to that of different imparipinnate but of the uniformity of the ex smooth to the latter. There is no basis in law for ignoring any belongings in fashioning such a examination. Id.

Thus the assembly liberally incited chemical exclusive rights applications as monthlong as a claimed creativity could epitomize new properties even yet the claimed palm-shaped mutual a corresponding composition with a antecedent art pedate. The Papesch court, however, did not operate with the requirements for establishing a stellar facie travel case of patency. The committee just command that, for cases beside a supposal of obviousness, an querier had to think over both the properties of the innovation and the noesis parallel. Id.